Know How Your GLP-1
Is Actually Working
Track your response to Ozempic, Wegovy, Mounjaro, and Zepbound with CLIA-certified molecular testing. We combine standard metabolic blood panels with proprietary mRNA gene expression analysis so you know your therapy is working weeks before your next weigh-in.
CLIA-Certified Laboratory
Philadelphia Facility
14-Day Turnaround
Complete reporting
Standard + mRNA
48 transcriptomic markers
What We Test:
Standard Labs Meets the Molecular Layer
A single blood draw captures standard safety markers and metabolic enzymes, alongside proprietary transcriptomic expression levels.
Metabolic Health
Insulin Sensitivity & Control
Tracks blood sugar regulation and metabolic baseline shifts over titration.
- · HbA1c
- · Fasting Insulin
- · Fasting Glucose
- · Lipids (LDL, HDL, Triglycerides)
Organ Safety
Kidney & Liver Tolerability
Monitors basic safety metrics to ensure organs tolerate GLP-1 weight loss progression.
- · Liver Enzymes (ALT, AST)
- · Kidney (Creatinine, BUN)
- · Complete Metabolic Panel (CMP)
- · TSH (Thyroid health)
Inflammation
Systemic & Vascular Health
Evaluates chronic inflammation drop-rates as therapy engages adipose tissue reduction.
- · hs-CRP
- · IL-6 (Cytokine response)
- · TNF-alpha Expression
- · WBC count
mRNA Response
Proprietary Molecular Layer
Measures cellular expression to detect therapy response and muscle loss weeks early.
- · 48 RNA target signatures
- · Muscle loss (MURF1 & MAFbx)
- · Metabolic pathway markers
- · Cellular inflammatory trends
How It Works:
From Sample to Results
A simple, clinical-grade 3-step process to access advanced transcriptomic insights.
Order Kit
Purchase your monitoring kit online or have your prescribing provider place the order. We ship collection materials directly to you or flag it for collection.
Collect Sample
Visit our flagship Philadelphia laboratory or partner drawing centers. Remote phlebotomy scheduling is also available.
Get Results + Interpretation
Your sample is run at our CLIA lab. Review standard markers and transcriptomic muscle-loss signals in an integrated report within 14 days.
What Clinicians & Patients
Are Saying
"Adding OHL's mRNA layer to my patients' GLP-1 protocols has completely transformed how we manage titration. We caught three cases of muscle catabolism at week 4, allowing us to pivot training and protein intake immediately before lean mass was lost."
Dr. Aris Ortiz, MD
Metabolic & Obesity Medicine Specialist
"I was losing weight but felt incredibly weak. One Health Labs' report showed my muscle breakdown genes were highly active, which standard blood tests missed completely. Increasing my protein and starting resistance training saved my energy and body composition."
Sarah M.
GLP-1 Patient (Wegovy®)
Explore Our Resources
Monitoring Hub
Explore our testing schedules, panels, biomarkers, and specialized mRNA assays.
Patient Guide
Find answers to pros and cons, non-response triggers, and high-volume clinical guides.
Science Hub
Deep dive into transcriptomic monitoring and how messenger RNA isolates gene response.
Clinicians Hub
Partner setups, EHR-ready reports, telehealth mail-in workflows, and integration details.